Amgen Inc.
Public
AMGN
SectorHealthcare
CountryUnited States
Market cap187.16B
A biotechnology pioneer that uses advanced human genetics to develop therapies for serious illnesses. It focuses on four high-stakes therapeutic areas: oncology, inflammation, rare diseases, and general medicine (including cardiovascular and bone health).
